Amazon One Medical GLP-1 Review 2026: The Most Integrated Program — One Week In
Amazon launched its GLP-1 Management Program on April 21, 2026, embedding obesity treatment inside primary care for the first time at scale. Same-day delivery to 3,000 cities, transparent pricing, and the full FDA-approved medication menu — but no behavioral coaching and brand new with zero outcome data.
Affiliate disclosure: Some links in this review are affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. Our ratings and editorial opinions are independent — we review all providers using the same criteria regardless of affiliate relationship.
What We Like
- Full FDA-approved GLP-1 menu: Wegovy (injection + pill), Zepbound (auto-injector + KwikPen), Foundayo
- Same-day delivery via Amazon Pharmacy to ~3,000 cities now, ~4,500 by end of 2026
- Lowest injectable cash-pay price of any reviewed platform — $299/month
- Oral GLP-1s from $149/month cash-pay; $25/month with qualifying insurance
- Manufacturer coupons automatically applied at Amazon Pharmacy checkout
- Primary care integration — weight management alongside cardiovascular, metabolic, and chronic care
- Both virtual AND in-person visits available across 200+ offices in 20+ cities
- Health AI assistant for prescription renewals, appointments, and medical questions
- Evidence-based treatment algorithms with standardized safety protocols
- No compounded medications — FDA-approved brand-name only
Watch Out For
- Launched April 21, 2026 — zero published outcome data yet
- No behavioral coaching, CBT curriculum, or registered dietitian included
- New GLP-1 prescriptions require being an existing One Medical primary care patient
- Prescription-only renewals ($29–$49) do not write new prescriptions
- One Medical membership required (~$199/year Prime, ~$299/year non-Prime) — adds to cost
- In-person offices in only 20+ US cities — not accessible everywhere
- Insufficient track record to evaluate care quality consistency at scale
- Insurance accepted for scheduled visits but NOT for the membership fee itself
Amazon One Medical launched its GLP-1 Management Program on April 21, 2026 — seven days ago at the time of this review. That newness is both its most important limitation and its most interesting feature. No other program in this review series has been evaluated this close to launch.
The announcement sent Hims & Hers stock down 6% on the day. That reaction tells you something about how the market read the competitive implications. Amazon is not just adding another telehealth GLP-1 prescriber. It is bringing together a primary care network, a national pharmacy with same-day delivery, an AI health assistant, and the full suite of FDA-approved GLP-1 medications into a single system — a structural integration that no pure telehealth platform can replicate.
Whether that integration translates into meaningfully better patient outcomes than Ro, Hims, or WW Clinic — we simply do not know yet. What we can evaluate is the model, the pricing, the medications, and who this program is most likely to serve well.
Context: What Amazon One Medical Actually Is
Amazon acquired One Medical for $3.9 billion in February 2023. One Medical is a membership-based primary care network with more than 200 in-person offices in 20+ US cities, plus virtual care available nationwide. It is not a telehealth startup — it is a full-service primary care organization with in-person clinics, employed clinicians, and electronic health records.
Amazon has integrated One Medical with Amazon Pharmacy to create a healthcare ecosystem where your primary care provider, your prescriptions, and your medication delivery are managed in one place. The GLP-1 Management Program launched April 21 is the first major clinical program to fully leverage this integration.
This background matters for understanding what Amazon One Medical is and is not. It is not a GLP-1-focused telehealth platform like Hims or Noom. It is a primary care organization that now offers GLP-1 management as an integrated chronic condition program — more analogous to seeing your primary care doctor for weight management, but with Amazon's logistics and pharmacy infrastructure underneath.
What the Program Offers
The core model
The GLP-1 Management Program at Amazon One Medical embeds obesity treatment into patients' existing primary care relationships. Key elements:
- Pre-visit screening to assess eligibility and goals before the consultation
- Structured consultation with your One Medical primary care clinician
- Regular follow-up visits with integrated monitoring of weight, metabolic markers, and comorbidities
- Standardized documentation using evidence-based treatment algorithms with built-in safety protocols
- Management of related conditions — hypertension, diabetes, cardiovascular disease — alongside weight loss, by the same clinician
- Amazon Pharmacy integration for prescription fulfillment with transparent pricing and manufacturer coupons automatically applied
The clinical model positions weight management as a chronic condition requiring ongoing medical supervision — not a one-time prescription event. Per Hemalee Patel, Senior Medical Director of Cardiometabolic Health at One Medical, the philosophy is explicit: "We don't feel like weight lives in a silo." That positioning is clinically sound and distinguishes the program from platforms where GLP-1 prescribing happens without knowledge of the patient's broader medical picture.
One Medical executives told Axios that some patients arriving from other providers are "malnourished" or on improper doses. That critique of the broader telehealth GLP-1 market — where async-only platforms prescribe without labs, without comorbidity context, and without follow-up — is pointed and credible. It is also the clearest articulation of what Amazon believes it does differently.
FDA-Approved Medications Available
| Medication | Form | Cash-Pay Price |
|---|---|---|
| Wegovy (semaglutide) | Daily oral pill | From $149/month |
| Foundayo (orforglipron) | Daily oral pill | From $149/month |
| Wegovy (semaglutide) | Weekly injection (pen) | From $299/month |
| Zepbound (tirzepatide) | Auto-injector | From $299/month |
| Zepbound (tirzepatide) | KwikPen (multi-dose) | From $299/month |
Amazon One Medical prescribes exclusively FDA-approved brand-name medications. No compounded GLP-1s — a deliberate clinical and regulatory choice that positions the program alongside WW Clinic and Calibrate as brand-name-only providers.
The medication menu is one of the broadest of any platform: both oral GLP-1 pills (Wegovy pill and Foundayo), both injectable options for Zepbound (standard auto-injector and the new multi-dose KwikPen), and injectable Wegovy. The Foundayo availability is particularly notable — the orforglipron pill was only approved April 1, 2026, making Amazon one of the first platforms to integrate it into a clinical program at launch.
Amazon Pharmacy: The Structural Advantage
The pharmacy integration is where Amazon has a genuine, durable advantage that pure telehealth platforms cannot replicate.
Transparent pricing with automatic coupon application
At Amazon Pharmacy checkout, patients see their insurance price and their cash-pay price side by side. Manufacturer savings cards from Novo Nordisk and Eli Lilly are automatically applied to eligible patients at checkout — no separate application, no codes to enter, no phone calls. Amazon Pharmacy reports its customers have saved over $200 million through this automatic coupon program.
This automatic application matters practically. At Hims or Ro, patients typically need to enroll in manufacturer savings programs separately. The friction is small but real — and some patients who are eligible for savings card pricing never apply for them. Amazon eliminates that friction entirely.
Same-day delivery
Amazon Pharmacy currently offers same-day delivery in approximately 3,000 cities and towns, expanding to approximately 4,500 by the end of 2026. No other GLP-1 telehealth platform offers same-day delivery infrastructure of comparable scale.
For patients in covered cities, same-day delivery meaningfully reduces the logistical friction of staying on a GLP-1 medication — no pharmacy trip, no coordination with specialty mail-order services, no waiting several days for the next supply. Medication adherence data consistently shows that access friction drives discontinuation, and same-day delivery reduces the single biggest logistical barrier.
The $5 Prime medication subscription
For Prime members, Amazon Pharmacy's $5/month medication subscription provides access to 50+ common generic medications for chronic conditions with free delivery. This is not directly relevant to GLP-1 brand-name medications (which are not generic), but it is relevant context: the infrastructure exists and is already being used by tens of millions of Prime members. Amazon is expanding that infrastructure into branded specialty medication management.
Pricing: Membership Plus Medication
Amazon One Medical requires membership for new GLP-1 prescriptions. The membership is priced separately from medication:
One Medical membership
| Membership | Annual Cost | Monthly Equivalent |
|---|---|---|
| Prime member pricing | ~$199/year | ~$16.58/month |
| Non-Prime pricing | ~$299/year | ~$24.92/month |
The membership covers:
- Unlimited on-demand virtual care (message and video)
- Same- or next-day in-person appointments at One Medical offices
- 24/7 Care Team messaging
- Health AI assistant access
- Insurance accepted for scheduled visits (in-person and scheduled video)
Note: The One Medical membership itself is not covered by insurance. On-demand care (message/video at pay-per-use pricing) is also not insurance-covered. Scheduled visits — including in-person and video appointments with your primary care provider — are billed to insurance with standard copays and deductibles.
All-in cost with membership (cash-pay)
| Medication | Medication | Membership (~$17/mo Prime) | Total |
|---|---|---|---|
| Oral GLP-1 (starter dose) | $149/mo | ~$17/mo | ~$166/mo |
| Oral GLP-1 (maintenance) | $299/mo | ~$17/mo | ~$316/mo |
| Injectable (Wegovy/Zepbound) | $299/mo | ~$17/mo | ~$316/mo |
For Prime members, the One Medical membership add-on is the lowest of any reviewed platform — approximately $17/month vs. $74–$149/month at competitor platforms. The all-in cash-pay injectable price of ~$316/month is competitive with NovoCare direct ($349/month) and meaningfully lower than Hims ($448/month all-in) or Ro ($448/month monthly plan).
With insurance
For patients with commercial insurance that covers Wegovy or Zepbound:
- Insurance handles the medication cost with standard copay/coinsurance
- Manufacturer savings cards are automatically applied at checkout
- Most insured patients pay $0–$25/month for medication after deductible
- Total all-in: ~$17–$42/month (membership + medication copay)
This positions Amazon One Medical as extremely competitive for insured Prime members — lower total cost than any other platform in this review series at the insured tier.
The prescription renewal option (no membership required)
For patients who already have an existing GLP-1 prescription from another provider and do not need a new evaluation, Amazon offers standalone prescription renewals:
- $29 for an on-demand message consultation
- $49 for an on-demand video visit
This is explicitly a renewal pathway — not a new prescription service. If you are already on Wegovy or Zepbound through Hims, Ro, or another provider and want to transfer your refills to Amazon Pharmacy for same-day delivery convenience, this is the relevant option. You would not need a One Medical membership for this pathway.
The Primary Care Integration: Why It's Clinically Different
This is Amazon's clearest differentiator and the one most worth examining carefully.
What "primary care integration" actually means
At Hims, Ro, or Sesame, a patient's GLP-1 prescriber has access to what the patient self-reports on an intake questionnaire. They do not have access to the patient's full medical history, lab history, medication list from other providers, or the context of conditions like hypertension, prediabetes, sleep apnea, or cardiovascular disease that coexist with obesity.
At Amazon One Medical, a GLP-1 prescription is issued by the same clinician who manages the patient's primary care. That clinician has:
- The complete medical record
- The existing relationship and trust
- Knowledge of all current medications and interactions
- The ability to monitor weight-related comorbidities as they improve
- The context to adjust GLP-1 dosing alongside changes in blood pressure medication, diabetes management, etc.
This integration is not cosmetic. The clinical case for managing GLP-1 therapy within primary care — rather than as a standalone prescription — is strong. Weight loss changes cardiovascular risk profiles, blood pressure, blood sugar, and kidney function. Those changes require monitoring and medication adjustment by someone who sees the whole patient. Most telehealth GLP-1 platforms cannot do this, because they do not have the full patient picture.
Evidence-based treatment algorithms
Amazon One Medical has implemented standardized treatment algorithms for GLP-1 prescribing — standardized documentation, built-in safety protocols, and structured follow-up cadences. This is clinical operations infrastructure that ensures every One Medical clinician prescribing GLP-1s follows the same evidence-based protocols rather than making individual judgment calls about titration pace, monitoring frequency, and safety screening.
Both virtual and in-person
Amazon One Medical is one of the only platforms in this review series that offers genuine in-person care as part of the GLP-1 program. For patients in cities with One Medical offices — currently 20+ metropolitan areas — the option to meet face-to-face with their clinician for the initial GLP-1 evaluation, lab review, or follow-up is meaningful. In-person visits often produce better patient engagement and communication than purely virtual alternatives.
The Health AI Assistant
Amazon launched its Health AI assistant for One Medical members earlier in 2026. Relevant capabilities for GLP-1 patients:
- Answer medical questions about GLP-1 medications, side effects, and dosing
- Explain lab results in plain language
- Manage prescription renewals automatically
- Book follow-up appointments
- Review health records and flag relevant information before consultations
This is not a clinical decision-maker — it does not prescribe or change treatment. But as a navigation and administrative layer, it reduces the friction of staying engaged with a GLP-1 program. Remembering to schedule a follow-up, understanding what a lab result means, renewing a prescription at the right time — these are real adherence barriers, and AI assistance reduces them.
What Amazon One Medical Does Not Offer
Being clear about limitations is particularly important for a brand-new program with no established track record.
No behavioral coaching program
Amazon One Medical does not include a behavioral coaching program, CBT curriculum, registered dietitian access, or structured lifestyle support. For patients who want the behavioral component that research shows amplifies GLP-1 outcomes and supports durability after medication, this is a significant gap.
If behavioral support matters to you, Noom Med, WeightWatchers Clinic, or Calibrate are better choices. Amazon One Medical is a medical and pharmacy integration platform, not a lifestyle program.
New prescriptions require One Medical membership
The $29–$49 renewal option is for existing GLP-1 patients only. If you do not currently have a GLP-1 prescription, you cannot get one through Amazon's renewal pathway. You need to become an Amazon One Medical primary care patient, which requires the annual membership.
In-person offices in only 20+ cities
Amazon One Medical has more than 200 offices in 20+ US cities — primarily major metropolitan areas including New York, Los Angeles, San Francisco, Seattle, Chicago, Boston, Washington DC, Atlanta, and others. Patients in rural areas or smaller cities have access to virtual care but not in-person visits.
Brand new — no outcome data
Every other platform reviewed on this site has published patient outcome data or exists in a form that can be evaluated against multi-year patient experience. Amazon One Medical's GLP-1 program is seven days old. We cannot evaluate:
- Average patient weight loss outcomes
- Medication persistence rates
- Quality of follow-up care at scale
- Insurance prior authorization effectiveness
- Customer service quality for GLP-1-specific issues
This is not a criticism of the program's design — it is a factual limitation. This review will be updated as outcome data becomes available.
Who Amazon One Medical Is Right For
Amazon One Medical is the strongest choice if:
- You are an Amazon Prime member in a metropolitan area with One Medical offices
- You have complex medical history — cardiovascular disease, prediabetes, hypertension — where GLP-1 management genuinely needs to be integrated with your broader care
- You want the lowest-friction pharmacy experience including same-day delivery and automatic coupon application
- You want the newest FDA-approved medications (including Foundayo, launched April 2026) from a platform with clinical infrastructure
- You are self-pay and want competitive injectable pricing (~$316/month all-in for Prime members)
- You already use Amazon Pharmacy and want to consolidate your healthcare
Amazon One Medical is not the right choice if:
- You want behavioral coaching, a lifestyle program, or registered dietitian access alongside your medication
- You are not in a city with a One Medical office and virtual-only primary care is not appealing
- You need a new GLP-1 prescription without signing up for a full primary care membership
- You want to evaluate a program with published outcome data before committing
- You need complex prior authorization management with a dedicated concierge team — the program is new and PA infrastructure is unproven at scale
Competitive Positioning: Where Amazon Fits
Amazon vs. Hims / Hers
Both offer the full FDA-approved medication menu. Hims is faster for getting a first prescription (async model, no membership required for consultation). Amazon One Medical offers primary care integration, in-person visits, and same-day delivery infrastructure that Hims cannot match. For Prime members in major cities who want clinical depth, Amazon is better. For pure speed and simplicity, Hims.
Amazon vs. Ro Body Program
Ro has a proven prior authorization concierge and established track record. Amazon has lower all-in pricing for Prime members and the pharmacy logistics advantage. The programs serve similar patients — commercially insured, seeking brand-name access — with different infrastructure strengths. As Amazon's PA process matures, this comparison will become more meaningful. For now, Ro is the lower-risk choice for insured patients with complex PA needs.
Amazon vs. WeightWatchers Clinic
WW Clinic has the behavioral program, the registered dietitian, and the community infrastructure that Amazon lacks. Amazon has better pharmacy logistics and lower all-in pricing for Prime members. These serve meaningfully different patient needs — patients who want lifestyle support alongside medication should choose WW Clinic; patients who want primary care integration and pharmacy convenience should choose Amazon.
Amazon vs. Calibrate
Calibrate is explicitly a behavior change program with GLP-1 medication as a tool; Amazon is a primary care integration with pharmacy convenience. They attract very different patients and are not in direct competition. Calibrate requires insurance and 12-month commitment; Amazon is accessible to both insured and self-pay patients without a program commitment.
Our Verdict
WeightRx Guide Rating: 4.1 / 5
Amazon One Medical earns a 4.1 with important asterisks on both sides.
On the upside: the structural integration of primary care, pharmacy, and GLP-1 management is genuinely the most coherent clinical model in the space. The pricing is competitive — especially for Prime members. The medication menu is complete. The same-day delivery infrastructure is unmatched. The Health AI assistant reduces adherence friction. And the positioning of GLP-1 management as a primary care chronic condition program, rather than a standalone prescription service, is clinically correct.
On the downside: the program is seven days old. No outcome data. No established track record on prior authorization, clinical quality consistency at scale, or customer service for GLP-1-specific issues. And there is no behavioral coaching — a genuine clinical gap relative to Noom, WW Clinic, and Calibrate.
We will revisit this rating in 90 days with more real-world experience data. For now: if you are a Prime member in a major city with a complex health history who wants your GLP-1 managed within a primary care relationship with same-day delivery, Amazon One Medical is the most structurally sound option available. If you want behavioral support, published outcome data, or proven prior authorization infrastructure, one of the established platforms is a lower-risk choice.
This review was published April 28, 2026 — one week after program launch. It will be updated as clinical and operational track record develops.
Frequently Asked Questions
Is Amazon One Medical's GLP-1 program actually new?
Yes. The formal GLP-1 Management Program launched April 21, 2026. Amazon One Medical and Amazon Pharmacy have offered GLP-1 prescriptions and fulfillment previously, but the structured program with standardized treatment algorithms, pre-visit screening, and integrated care protocols is new as of that date.
Do I need to be a Prime member to use it?
No — but Prime membership reduces the One Medical annual membership cost from approximately $299/year to $199/year. Prime membership itself costs $139/year. If you are not already a Prime member, the combined Prime + One Medical membership costs approximately $338/year, vs. $299/year without Prime. Do the math for your situation.
Can I get a new GLP-1 prescription without a One Medical membership?
No. The $29–$49 on-demand telehealth option is for prescription renewals only — patients who already have a GLP-1 prescription from a provider. New prescriptions require an Amazon One Medical primary care membership and consultation.
Does Amazon One Medical accept insurance for GLP-1 visits?
Yes — scheduled visits (in-person and scheduled video) are billed to insurance with standard copays and deductibles. The One Medical annual membership itself is not covered by insurance. On-demand care (the $29–$49 renewal option) is also cash-pay only.
What is the Health AI assistant?
Amazon launched a Health AI assistant for One Medical members in early 2026. It can answer questions about your medications and lab results, help you book appointments, manage prescription renewals, and navigate your health records. It is not a clinical decision-maker and does not prescribe medication.
Which cities have Amazon One Medical offices?
One Medical has 200+ offices in 20+ US metropolitan areas including New York, Los Angeles, San Francisco, Seattle, Chicago, Boston, Washington DC, Atlanta, Austin, Denver, Houston, Miami, Phoenix, Portland, and others. Check onemedical.com for current locations. Nationwide virtual care is available to all US patients regardless of location.
Does Amazon One Medical offer compounded GLP-1 medications?
No. Amazon One Medical prescribes FDA-approved brand-name medications only through Amazon Pharmacy: Wegovy (injection and oral pill), Zepbound (auto-injector and KwikPen), and Foundayo. No compounded semaglutide or tirzepatide.
How does same-day delivery work for GLP-1 medications?
Amazon Pharmacy fulfills GLP-1 prescriptions for delivery to all 50 states. In approximately 3,000 cities currently (expanding to ~4,500 by end of 2026), same-day delivery is available for orders placed before the daily cutoff. In other areas, 1–2 day delivery is standard. The specific cities and cutoff times for same-day delivery are listed at pharmacy.amazon.com.
Amazon One Medical
The most structurally integrated GLP-1 program available — primary care, pharmacy, and obesity treatment in one system. Best for Prime members with complex health histories who want genuine medical oversight. Too new to evaluate outcomes.
Sponsored · FDA-approved medications only · Independent review